A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Our Business We are a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions that enable our customers to explore life and materials at microscopic, molecular and cellular levels. Many of our products are used to detect, measure and visualize structural characteristics of chemical, biological and industrial material samples. Our products and solutions address the rapidly evolving needs of a diverse array of customers in life and materials science research, biopharmaceuticals, applied markets, microbiology, in-vitro diagnostics, and nanotechnology. Our technology platforms include magnetic resonance, mass spectrometry, gas and liquid chromatography, X-ray, microscopy, metrology, and molecular spectroscopy technologies.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 3.4B | 3.4B | 3.4B | 3.0B | 2.5B | 2.4B |
| Net Income | -23M | -23M | 113M | 427M | 297M | 277M |
| EPS | $-0.15 | $-0.15 | $0.76 | $2.90 | $1.99 | $1.81 |
| Free Cash Flow | 43M | 43M | 136M | 243M | 145M | 190M |
| ROIC | -5.4% | 1.0% | 4.5% | 14.5% | 20.9% | 25.5% |
| Gross Margin | 45.9% | 45.9% | 49.0% | 51.0% | 51.6% | 50.0% |
| Debt/Equity | 0.83 | 0.83 | 1.28 | 1.55 | 1.14 | 1.25 |
| Dividends/Share | $0.15 | $0.15 | $0.20 | $0.20 | $0.16 | $0.16 |
| Operating Income | 68M | 68M | 253M | 437M | 433M | 413M |
| Operating Margin | 2.0% | 2.0% | 7.5% | 14.7% | 17.1% | 17.1% |
| ROE | -0.9% | -1.1% | 7.2% | 34.3% | 27.2% | 27.3% |
| Shares Outstanding | 150M | 150M | 149M | 147M | 149M | 153M |
BRUKER CORP passes 3 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 137.3x vs a median of 48.5x. The company's 5-year average ROIC is 13.3% with a gross margin of 49.5%. Total shareholder yield (dividends + buybacks) is 0.6%. At current prices, the estimated annualized return to fair value is -8.8%.
BRUKER CORP (BRKR) has a 5-year average return on invested capital (ROIC) of 13.3%. This indicates solid capital allocation.
BRUKER CORP (BRKR) has a market capitalization of $5.9B. It is classified as a mid-cap stock.
Yes, BRUKER CORP (BRKR) pays a dividend with a trailing twelve-month yield of 0.39%. The company also returns capital through share buybacks, with a buyback yield of 0.17%.
BRUKER CORP (BRKR) operates in the Laboratory Analytical Instruments industry, within the Technology sector.
BRUKER CORP (BRKR) reported annual revenue of $3.4 billion in its most recent fiscal year, based on SEC EDGAR filings.
BRUKER CORP (BRKR) has a net profit margin of -0.7%. The company is currently unprofitable.
BRUKER CORP (BRKR) generated $43 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
BRUKER CORP (BRKR) has a debt-to-equity ratio of 0.83. This indicates moderate leverage.
BRUKER CORP (BRKR) reported earnings per share (EPS) of $-0.15 in its most recent fiscal year.
BRUKER CORP (BRKR) has a return on equity (ROE) of -1.1%. A negative ROE may indicate losses or negative equity.
BRUKER CORP (BRKR) has a 5-year average gross margin of 49.5%. This indicates decent pricing power.
The Ledger Terminal provides 17 years of financial data for BRUKER CORP (BRKR), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
BRUKER CORP (BRKR) has a book value per share of $16.38, based on its most recent annual SEC filing.
No recent press releases.